Galectin Therapeutics

Grid Insight

About

Galectin Therapeutics, Inc. (NASDAQ: GALT) is the leading developer of compounds that target galectin proteins to treat fibrosis and cancer. Building upon positive preclinical studies in animals, the company’s primary focus is on NASH (non-alcoholic steatohepatitis) with advanced fibrosis and…

Services and Fees

Finance: Commercial Banking, Lending, Underwriting

Join The Grid to view full services and fees information

Organization type

Capital Provider

Ask Zolid AI

How do I figure out which path fits my company?What are the motivations of third party buyers?What are the different types of employee ownership?

Details

Funding source: Other

Curators

No one has curated this page yet. Be the first.

Curate

Meet Zolid AI

Meet Zolid AI

Add this org to the EO Market Map

About

Services and Fees

Join The Grid to view full services and fees information

Organization type

Ask Zolid AI

Details

Contact

Associated people

Current

Previous

Authored

Mentions

Curators